GELS

Gelteq Limited Ordinary Shares
GELS
Market cap $15.1M

1.60 USD

+0.01

0.63%

Updated Nov 19, 3:15 PM EST

1 day

0.63%

5 days

-29.52%

1 month

-32.49%

3 months

-32.49%

6 months

-32.49%

Year to date

-32.49%

1 year

-32.49%

5 years

-32.49%

10 years

-32.49%

About: Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.

–

Funds holding %

of 6,735 funds

–

Analysts bullish %

Fund manager confidence

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for GELS.

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about GELS published over the past 30 days

Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, announced today that it has expanded its operations in the United States with the appointment of Adam Bendell as President of U.S. Operations.

Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

Gelteq Limited Closes US$5.2 Million Initial Public Offering

NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the closing of its initial public offering of 1,300,000 ordinary shares at a public offering price of US$4.00 per share. The ordinary shares commenced trading on the Nasdaq Global Market on October 29, 2024 under the symbol “GELS.”

Gelteq Limited Closes US$5.2 Million Initial Public Offering

Gelteq Limited Prices US$5.2 Million Initial Public Offering

Company anticipates commencement of trading on Nasdaq effective October 29, 2024 under the symbol “GELS” Company anticipates commencement of trading on Nasdaq effective October 29, 2024 under the symbol “GELS”

Gelteq Limited Prices US$5.2 Million Initial Public Offering

See News Rankings

Charts implemented using Lightweight Charts™